MoleculeMind Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $100M

  • Investors
  • 20

MoleculeMind General Information

Description

Developer of an integrated biological computing system designed to facilitate protein design. The company's technology utilises deep learning algorithms and first-principles physics for ultra-high-precision dynamic protein design, enabling biopharmaceutical companies to predict complex structures, optimise industrial enzymes, and design custom proteins with enhanced physical properties.

Contact Information

Website
www.moleculemind.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 20, Number 1 Courtyard, Baosheng South Road
  • Haidian District
  • Beijing, 100192
  • China
+86 157
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • Building 20, Number 1 Courtyard, Baosheng South Road
  • Haidian District
  • Beijing, 100192
  • China
+86 157

MoleculeMind Timeline

2023202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MoleculeMind Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A1) 17-Jun-2026 $100M Completed Generating Revenue
3. Early Stage VC (Series A) 13-Sep-2024 Completed Generating Revenue
2. Early Stage VC 08-Feb-2023 $14.8M $14.8M Completed Generating Revenue
1. Seed Round 18-Apr-2022 Completed Startup
To view MoleculeMind’s complete valuation and funding history, request access »

MoleculeMind Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an integrated biological computing system designed to facilitate protein design. The company's technology u
Discovery Tools (Healthcare)
Beijing, China

Middletown, DE
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MoleculeMind Competitors (1)

One of MoleculeMind’s competitors is Earendil Labs, a Venture Capital-Backed company based in Middletown, DE.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Earendil Labs Venture Capital-Backed Middletown, DE
You’re viewing 1 of 1 competitors. Get the full list »

MoleculeMind Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Blue Bridge Advisors Corporation Minority
Fosun Venture Capital Investment Corporate Venture Capital Minority
Hunan Caixin Investment Holding Group Government Minority
Infinity Group PE/Buyout Minority
NeuX Capital Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

MoleculeMind Investments (1)

MoleculeMind’s most recent deal was a Early Stage VC with Essentia BioSciences. The deal was made on 24-Oct-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Essentia BioSciences 24-Oct-2023 Early Stage VC Biotechnology
To view MoleculeMind’s complete investments history, request access »

Ready to get started?

Request a free trial

MoleculeMind FAQs

  • When was MoleculeMind founded?

    MoleculeMind was founded in 2022.

  • Where is MoleculeMind headquartered?

    MoleculeMind is headquartered in Beijing, China.

  • What industry is MoleculeMind in?

    MoleculeMind’s primary industry is Discovery Tools (Healthcare).

  • Is MoleculeMind a private or public company?

    MoleculeMind is a Private company.

  • What is MoleculeMind’s current revenue?

    The current revenue for MoleculeMind is .

  • How much funding has MoleculeMind raised over time?

    MoleculeMind has raised $115M.

  • Who are MoleculeMind’s investors?

    Blue Bridge Advisors, Fosun Venture Capital Investment, Hunan Caixin Investment Holding Group, Infinity Group, and NeuX Capital are 5 of 20 investors who have invested in MoleculeMind.

  • Who are MoleculeMind’s competitors?

    Earendil Labs is a competitor of MoleculeMind.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process